Nottingham Trent University researchers devised a finger-prick technique to accurately detect brain cancers, which could revolutionise brain tumour diagnosis and treatment. Tumors send genetic material into the circulation, which the finger-prick test discovers within hours. This non-invasive, affordable diagnostic should help distant and disadvantaged people survive and get quick treatment. Within five years, researchers expect to release the test…
A brain tumour diagnosis is alarming for everyone. Detecting and treating this cancer is tough, making it one of the hardest to fight. Recent news regarding a brain tumour testing breakthrough gives millions of patients hope.
A brain tumor finger-prick diagnostic developed by Nottingham Trent University (NTU) researchers is accurate. It could revolutionise brain tumour diagnosis and therapy, changing the fight against this deadly illness.
Prof. Philippe Wilson of Nottingham Trent told The Guardian: “Brain tumours are managed with the best available treatments when first diagnosed, but unfortunately recurrence is a major problem and some come back very quickly and aggressively. If you undergo an MRI six months following treatment, a tumor may have returned for a long time.
It’s hard to imagine a more extensively utilized and understood medical technology than the lateral flow test. This easy-to-use equipment would check patients’ diseases at home often and cheaply. We intend to apply the research to other cancers to save millions more lives.”
Brain tumors are diagnosed via MRI and biopsies. These procedures are expensive, obtrusive, and time-consuming. Many brain tumors go undiagnosed until it’s too late.
Dr. Ola Rominiyi, of the University of Sheffield “Currently, patients often have follow-up MRI scans every three to six months, but successful development of a lateral flow test to detect brain cancer could make it possible to efficiently test for recurrence every week, so that more recurrent tumours are caught early, at a more treatable stage” .
Tumors emit microscopic genetic pieces into the circulation, which the new finger-prick test detects. One of the biggest benefits of this new exam is its quickness. This finger-prick test can diagnose in hours, unlike standard procedures that take weeks. Aggressive brain tumors that need rapid therapy necessitate this fast turnaround.
Compared to other diagnostic procedures, this test is non-invasive and affordable. This makes it accessible to isolated or disadvantaged populations without superior medical services.
This breakthrough could have huge implications. With faster and more precise diagnosis, patients can receive therapy sooner, boosting survival. This test can also track therapy efficacy and detect tumor recurrence for prompt treatment. The researchers behind this innovation expect to release the test within five years.
Conclusion
The invention of a finger-prick brain tumor test is a medical breakthrough. This non-invasive, inexpensive, and fast diagnostic could change brain tumour diagnosis and treatment, especially in distant or disadvantaged places. Early tumor detection and therapy monitoring increase patient outcomes and survival. The researchers’ objective of making the test public within five years is encouraging for cancer care worldwide.
